HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lasek for myopia: first results.

AbstractPURPOSE:
To evaluate the efficacy and safety of laser-assisted subepithelial keratectomy (LASEK) for the treatment of myopia and astigmatism (low, moderate and high).
MATERIAL AND METHODS:
Laser-assisted subepithelial keratectomy was performed by 3 surgeons in 45 eyes using an INPRO Gauss Excimer laser (31 eyes) or a NIDEK EC-5000 Excimer Laser (14 eyes). The mean follow-up is 9 months (3-15 months). Preoperative best-corrected visual acuity (BCVA) and corneal topography were measured. The postoperative parameters were: uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), spherical equivalent refraction (SER), defocus equivalent refraction (DER), and corneal topography.
RESULTS:
The mean preoperative sphere and cylinder were -4.09 diopters (D) +/- 1.94 D (range -1.25 D to -9.75 D) and -0.67 D +/- 0.55 D (range 0 D to -2.50 D) respectively. No eye lost 2 or more lines of BCVA. The UCVA was > or = to 20/20 in 56% of the cases and 20/40 or better in 100% of the cases. No eye developed corneal haze that affected visual acuity. No major complications were recorded.
CONCLUSIONS:
LASEK treatment is a safe and effective technique for treatment of low to high myopia. This surgical technique is less invasive and more effective than LASIK because of the lack of flap- and microkeratome-related complications.
AuthorsT Vandorselaer, J J Hermiat, P Schraepen, R Trau, M J Tassignon
JournalBulletin de la Societe belge d'ophtalmologie (Bull Soc Belge Ophtalmol) Issue 290 Pg. 59-68 ( 2003) ISSN: 0081-0746 [Print] Belgium
PMID14750232 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Adult
  • Follow-Up Studies
  • Humans
  • Keratomileusis, Laser In Situ
  • Middle Aged
  • Myopia (surgery)
  • Prospective Studies
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: